



 Crohn’s disease (CD) is one of the major type of inflammatory bowel diseases 
(IBD) that affects the gastrointestinal tract. There were a lot of susceptible genes being 
published based on different population studies as well as meta-analysis projects. In this 
study, we aimed to investigate the association of some genes, NOD1, CXCL16, STAT6, 
TLR4, ATG16L1 and IRGM had been found with association to the disease on non-
Malaysian population. Overall, 85 CD DNA samples and 250 control healthy samples 
were collected from University Malaya Medical Center (UMMC). DNA were extracted 
and analyzed by polymerase chain reaction-restriction fragment length polymorphism 
(PCR-RFLP) or TaqMan assay amplification. Results obtained showed that NOD1 
(PG/A=0.5179, ORG/A=1.135, 95% CIG/A=0.786 – 1.637), STAT6 (PA/G=0.531, 
ORA/G=0.884, 95% CIA/G=0.621 - 1.258) and IRGM variants (Prs4958847=0.154, 
Prs11747270=0.09359, Prs72553867=0.8844) had no association with CD. CXCL16 
(PC/T=0.04819, ORC/T=1.431, 95% CIC/T=1.009 - 2.031), TLR4 (PC/T=0.007, 
ORC/T=0.437, 95% CIC/T=0.242 - 0.789) and ATG16L1 variant rs2241880 
(PA/G=0.01462, ORA/G=0.645, 95% CIA/G =0.454 - 0.917) were found to be associated 
with Malaysian patients. For stratified analysis, TLR4 (P=0.0002399) and ATG16L1 
rs2241880 variant (P=0.03619) were significantly associated with Malay while 
ATG16L1 variant 6754677 (P=6.3x10-3) was associated with Indian patients. In 
conclusion, CXCL16, TLR4 and ATG16L1 but not NOD1, STAT6 and IRGM were found 








Penyakit Crohn (CD) merupakan salah satu kelas daripada penyakit debu 
inflamatori (IBD) yang menjangkiti seluruh trek gastrousus. Pelbagai gen telah ditemui 
sebagai faktor penyakit CD melalui pelbagai kajian yang dijalankan atas populasi 
tertentu ataupun kajian meta-analisis. Dalam kajian ini beberapa gen telah dipilih iaitu 
NOD1, CXCL16, STAT6, TLR4, ATG16L1 dan IRGM telah diistihar berhubung dengan 
penyakit dalam populasi asing. Varian yang terkandung dalam gen-gen diperiksa 
dengan 85 sampel pesakit CD dan 250 sampel kawalan yang dikumpul dari Pusat 
Perubatan Universiti Malaya (PPUM). DNA diekstrek sebelum dianalisis melalui reaksi 
rantai polimerase- polimorfisme panjang berkas restriksi (PCR-RFLP) atau amplifikasi 
asai TaqMan. Hasil menunjukkan tiada hubungan jelas untuk NOD1 (PG/A=0.5179, 
ORG/A=1.135, 95% CIG/A=0.786 – 1.637), STAT6 (PA/G=0.531, ORA/G=0.884, 95% 
CIA/G=0.621 - 1.258) dan IRGM (Prs4958847=0.154, Prs11747270=0.09359, Prs72553867=0.8844) 
dengan CD. Hasil daripada CXCL16 (PC/T=0.04819, ORC/T=1.431, 95% CIC/T=1.009 - 
2.031), TLR4 (PC/T=0.007, ORC/T=0.437, 95% CIC/T=0.242 - 0.789) dan varian 
ATG16L1 rs2241880 (PA/G=0.01462, ORA/G=0.645, 95% CIA/G =0.454 - 0.917) didapati 
berkait dengan CD di Malaysia. Dalam analysis berasaskan kaum, TLR4 (P=0.0002399) 
dan varian ATG16L1 rs2241880 (P=0.03619) didapati berkait rapat dengan kaum 
Melayu manakala varian ATG16L1 6754677 (P=6.3x10-3) adalah dengan kaum India. 
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